Eterna Therapeutics (ERNA) Q4 2024 Annual Earnings
ERNA·Reported March 12, 2025·Before market open
Eterna Therapeutics reported Q4 2024 revenue of $1.0K. Diluted EPS came in at $-1.14.
Revenue
$1.0K
Diluted EPS
$-1.14
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Eterna Therapeutics's Q4 2024 earnings report.
Eterna Therapeutics (ERNA) reported Q4 2024 earnings on March 12, 2025 before market open.
Eterna Therapeutics reported revenue of $1.0K and diluted EPS of $-1.14 for Q4 2024.
You can read the 10-K periodic report (0001493152-25-010051) directly on SEC EDGAR. The filing index links above go to sec.gov.